CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,674 enrolled
Drug / intervention
Superion® Indirect Decompression System (IDS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04087811
NCT04087811N/ACompleted
CompareCT.gov

Postmarket Registry for Evaluation of the Superion® Spacer

Boston Scientific Corporation·observational·Posted Sep 12, 2019·Updated Jul 6, 2023

In Brief

An observational study evaluating Superion® Indirect Decompression System (IDS) for Lumbar Spinal Stenosis. Completed, enrolled 1,674 participants across 66 sites.

Detailed Summary

To gather evidence documenting the performance and clinical outcomes associated with treatment of moderate degenerative lumbar spinal stenosis using the Superion® Indirect Decompression System (IDS).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLumbar Spinal Stenosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 12, 2019
Enrollment StartNov 28, 2016
Primary CompletionMar 1, 2021
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 6.8 years ago

Interventions

Superion® Indirect Decompression System (IDS)device

Superion® Indirect Decompression System (IDS) (Superion® implant)